Oncternal Therapeutics Inc
(ONCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 23,096 | 28,516 | 21,012 | 20,645 | 23,089 |
| Marketable Securities | N/A | N/A | 175 | N/A | 14,984 |
| TOTAL | $24,055 | $29,871 | $22,534 | $21,210 | $40,144 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 12 | N/A | 28 |
| Intangibles | 0 | 0 | 90 | 0 | 97 |
| Other Non-Current Assets | 994 | 1,032 | 0 | 752 | 0 |
| TOTAL | $994 | $1,032 | $102 | $752 | $125 |
| Total Assets | $25,049 | $30,903 | $22,636 | $21,962 | $40,269 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,231 | 2,765 | 609 | 3,440 | 3,121 |
| Accrued Expenses | 2,435 | 2,550 | 1,210 | 891 | 6,184 |
| TOTAL | $6,770 | $7,841 | $1,819 | $4,331 | $9,305 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 3,008 | 2,387 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 129 | 126 | 0 | 47,262 | 0 |
| TOTAL | $129 | $126 | $N/A | $47,262 | $N/A |
| Total Liabilities | $6,899 | $7,967 | $1,819 | $51,593 | $9,305 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 769 | 769 | 172 | 172 | 172 |
| Common Shares | 15 | 15 | 24 | 5 | 24 |
| Retained earnings | -61,416 | -56,524 | -605,857 | -31,384 | -594,640 |
| TOTAL | $18,150 | $22,936 | $20,817 | $-29,631 | $30,964 |
| Total Liabilities And Equity | $25,049 | $30,903 | $22,636 | $21,962 | $40,269 |